Literature DB >> 35535097

Tacrolimus-induced Central Pontine Myelinolysis in a Pediatric Liver Transplant Recipient.

Kinisha Patel1, Jagadeesh Menon1, Naresh Shanmugam1, Srinivasan Kalyanasundaram2, Mohamed Rela3.   

Abstract

Central pontine myelinolysis (CPM) is a rare neurological complication reported in liver transplant recipients. A 16-year-old boy with Wilson disease underwent a living donor liver transplant for acute-on-chronic liver failure. On postoperative day 7, he was noted to have diplopia, dysphagia, and bilateral lower limb weakness with wide base gait with gradual progression to akinetic mutism. Magnetic resonance imaging (MRI) brain was performed which was suggestive of CPM, and it was attributed to tacrolimus. We stopped tacrolimus, and he was started on ciclosporin. His neurological symptoms started improving after 72 hours and he had a complete clinical recovery by 6 weeks. Repeat MRI brain at 16 weeks after liver transplantation showed complete radiological resolution of the pontine lesion.
© 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Year:  2021        PMID: 35535097      PMCID: PMC9077162          DOI: 10.1016/j.jceh.2021.07.011

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  11 in total

1.  Central pontine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation.

Authors:  Kyota Fukazawa; Seigo Nishida; Luz Aguina; Ernesto Pretto
Journal:  Ann Transplant       Date:  2011 Jul-Sep       Impact factor: 1.530

2.  EFNS guidelines on management of neurological problems in liver transplantation.

Authors:  M Guarino; J Benito-Leon; J Decruyenaere; E Schmutzhard; K Weissenborn; A Stracciari
Journal:  Eur J Neurol       Date:  2006-01       Impact factor: 6.089

3.  Central pontine myelinolysis.

Authors:  J M S Pearce
Journal:  Eur Neurol       Date:  2008-11-25       Impact factor: 1.710

4.  Tacrolimus-induced permanent asymptomatic pontine myelinolysis after liver transplantation.

Authors:  Jianfeng Bao; Hui Liang
Journal:  Intern Med       Date:  2014-08-01       Impact factor: 1.271

Review 5.  Central pontine myelinolysis: a case report and clinical-pathological review.

Authors:  Rosa Cui; Sameh Fayek; Elizabeth B Rand; Tamara Feygin; Dmitry Khrichenko; Abraham Shaked
Journal:  Pediatr Transplant       Date:  2011-10-24

6.  Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol.

Authors:  P C de Groen; A J Aksamit; J Rakela; G S Forbes; R A Krom
Journal:  N Engl J Med       Date:  1987-10-01       Impact factor: 91.245

Review 7.  Osmotic demyelination syndrome: central pontine myelinolysis and extrapontine myelinolysis.

Authors:  Anthony M Alleman
Journal:  Semin Ultrasound CT MR       Date:  2013-09-28       Impact factor: 1.875

Review 8.  Central pontine myelinolysis following pediatric living donor liver transplantation: a case report and review of literature.

Authors:  Hajime Uchida; Seisuke Sakamoto; Kengo Sasaki; Ikumi Hamano; Takanobu Shigeta; Hiroyuki Kanazawa; Akinari Fukuda; Shunsuke Nosaka; Masaya Kubota; Mureo Kasahara
Journal:  Pediatr Transplant       Date:  2014-04-12

9.  Possible causes of central pontine myelinolysis after liver transplantation.

Authors:  Jun Yu; Shu-Sen Zheng; Ting-Bo Liang; Yan Shen; Wei-Lin Wang; Qing-Hong Ke
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

10.  Risk factors for central pontine and extrapontine myelinolysis following orthotopic liver transplantation.

Authors:  Eun Mi Lee; Joong Koo Kang; Sung-Cheol Yun; Ki-Hun Kim; Sang Joon Kim; Kyu-Sam Hwang; Sung-Gyu Lee
Journal:  Eur Neurol       Date:  2009-09-30       Impact factor: 1.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.